TK

Tarun Kumar

Active Director Director DIN 09841510
DIN 09841510 First appointment Dec 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value •••• Premium profile

About Tarun Kumar

Data last updated:

Tarun Kumar is a Director at Dasya Pharma Private Limited (since 2022). The company operates in Healthcare. Dasya Pharma Private Limited reported revenue of ₹64.2 Lakh (FY 2024).

DIN 09841510
Primary Designation Director
Industry Healthcare
First Appointment 29 Dec 2022
Oldest Company Age 3 yrs
Largest company Dasya Pharma Private Limited · ₹64.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dasya Pharma Private Limited U24290UR2022PTC015075
Director29 Dec 20222022₹64.2 Lakh (FY 2024)Active

Board colleagues of Tarun Kumar

NameDINCompanyDesignation
Tanu Rani09841509Dasya Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dasya Pharma Private Limited
Premium access

Shareholding and investment profile for Tarun Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tarun Kumar

Tarun Kumar currently holds 1 directorship: Dasya Pharma Private Limited (Director, since 29 Dec 2022, revenue ₹64.2 Lakh (FY 2024)).

Tarun Kumar was first appointed on 29 Dec 2022 as Director at Dasya Pharma Private Limited.

The current boards of Tarun Kumar's companies include Tanu Rani (Dasya Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available